Elisabeth Turpin

Exquisite Sensitivity of TP53 Mutant and Basal Breast Cancers to a Dose-Dense Epirubicin−Cyclophosphamide Regimen

Philippe Bertheau, Elisabeth Turpin, David S. Rickman et al. · PLoS Medicine · 2007 · 173 citations · Full text

Medicine, Oncology, Pharmacology +15

High Frequency of <i>TP53</i> Mutation in <i>BRCA1</i> and Sporadic Basal-like Carcinomas but not in <i>BRCA1</i> Luminal Breast Tumors

Élodie Manié, Anne Vincent‐Salomon, Jacqueline Lehmann‐Che et al. · Cancer Research · 2009 · 153 citations · Full text

Medicine, Genetics, Oncology +13

Prognostic significance of bcl-xL gene expression and apoptotic cell counts in follicular lymphoma

Weili Zhao, Marjan Daneshpouy, Nicolas Mounier et al. · Blood · 2003 · 66 citations · Full text

Medicine, Hematology, Oncology +13

In adrenocortical tissue, annexins II and VI are attached to clathrin coated vesicles in a calcium-independent manner1In memoriam: This last work as well as my scientific accomplishment are dedicated to the memory of Jeffries Wyman who was my best teacher and the most humane of all scientists I have ever met. Annette Alfsen.1

Elisabeth Turpin, Françoise Russo‐Marie, Thierry Dubois et al. · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · 1998 · 56 citations

Life Sciences, Cell Biology, Physiology +14

Cyclophosphamide Dose Intensification May Circumvent Anthracycline Resistance of <i>p53</i> Mutant Breast Cancers

Jacqueline Lehmann‐Che, Fabrice André, Christine Desmedt et al. · The Oncologist · 2010 · 53 citations · Full text

Medicine, Oncology, Pharmacology +16